E-4031: hERG Potassium Channel Blocker for Cardiac Electrophysiology Research

Executive Summary: E-4031 (APExBIO, SKU B6077) is a highly selective blocker of the hERG potassium channel with an IC50 of 7.7 nM, widely used for cardiac electrophysiology research and proarrhythmic substrate modeling (product page). In vitro, E-4031 prolongs action potential duration, depolarizes maximum diastolic potential, and induces early afterdepolarizations (EADs) and torsades de pointes (TdP) at nanomolar concentrations. In vivo, it inhibits the rapid delayed rectifier potassium current (Ikr), prolongs the QT interval, and creates a proarrhythmic substrate, especially under bradycardic conditions. The compound is supplied as a solid with a molecular weight of 401.52 and is soluble in DMSO and ethanol under specified conditions. E-4031 is intended strictly for research use, with rigorous documentation of purity and handling requirements (APExBIO).

Biological Rationale

ATP-sensitive potassium channels (K_ATP) are distributed in cardiac muscle, pancreatic beta cells, and the brain. These channels link cellular metabolism to electrical excitability, opening in response to decreased ATP and increased ADP levels (APExBIO). The hERG (human Ether-à-go-go-Related Gene) potassium channel, encoded by KCNH2, is critical for the rapid delayed rectifier potassium current (Ikr) in cardiac repolarization (related article). Disruption of hERG function results in delayed ventricular repolarization and QT interval prolongation, predisposing to arrhythmias such as TdP. E-4031 provides a robust tool for dissecting these pathophysiological mechanisms in both in vitro and in vivo models, extending on scenario-driven guidance for laboratory workflow and assay consistency (see here for troubleshooting typical lab challenges).

Mechanism of Action of E-4031

E-4031 is a potent and selective inhibitor of the hERG potassium channel. It binds to the channel pore, blocking the Ikr current at nanomolar concentrations (IC50 = 7.7 nM; measured at 22°C, pH 7.4) (product documentation). By inhibiting the Ikr current, E-4031 prolongs the cardiac action potential duration (APD), depolarizes the maximum diastolic potential, and reduces both the upstroke velocity and diastolic depolarization rate. These effects are observable in patch-clamp and cardiac tissue assays. In whole-animal models, E-4031 delays ventricular repolarization, prolongs the QT and activation recovery intervals (ARI), and can induce EADs and TdP, particularly in mid-myocardial regions during bradycardia (refining 3D-organoid data).

Evidence & Benchmarks

• E-4031 inhibits the hERG potassium channel with an IC50 of 7.7 nM (22°C, pH 7.4) (APExBIO).
• In vitro, E-4031 induces early afterdepolarizations (EADs) and prolongs the action potential duration in cardiac myocytes (mechanistic review).
• E-4031 delays repolarization and prolongs the QT interval and ARI in in vivo animal models, with maximal effects at bradycardia (Sanad et al. 2022, Table 2).
• The compound is insoluble in water, but dissolves at ≥103 mg/mL in DMSO and ≥9.66 mg/mL in ethanol with gentle warming and ultrasound (spec sheet).
• Purity is consistently ≥98% by HPLC, and solid compound must be stored at -20°C (APExBIO).
• E-4031 is for research use only and is not approved for diagnostic or therapeutic applications (APExBIO).

Applications, Limits & Misconceptions

E-4031 is a gold-standard tool in cardiac electrophysiology research for modeling proarrhythmic risk, benchmarking QT interval prolongation, and dissecting Ikr channel pharmacology. It supports high-fidelity proarrhythmic substrate modeling in both 2D and 3D tissue and organoid systems (3D modeling contrast: this article details solution handling and benchmark data not covered in organoid workflows). Recent studies highlight its use in translational research, particularly for preclinical safety pharmacology and mechanistic dissection of arrhythmogenic triggers (strategic applications—this article updates translational relevance and handling details).

Common Pitfalls or Misconceptions

• Not a pan-potassium channel blocker: E-4031 is selective for hERG and does not block all K⁺ channels.
• Not suitable for clinical therapy: The compound is strictly for research; it is not approved for human or veterinary use.
• Storage/shelf-life limits: Working solutions are not stable for long-term storage; always prepare fresh aliquots.
• Solubility restrictions: Insoluble in water; use DMSO or ethanol per guidelines for stock solutions.
• Proarrhythmic risk: Induces TdP and EADs in vitro and in vivo; use in safety-screened laboratory settings only.

Workflow Integration & Parameters

E-4031 (SKU B6077) is supplied as a solid compound with a molecular weight of 401.52 and chemical formula C₂₁H₂₇N₃O₃S (full documentation). For laboratory use, dissolve in DMSO (≥103 mg/mL) or ethanol (≥9.66 mg/mL) with gentle warming and ultrasound. Store at -20°C and avoid repeated freeze-thaw cycles. Do not use aqueous buffers directly due to insolubility. Shipping is performed on blue ice to preserve compound integrity. E-4031 is compatible with patch-clamp, optical mapping, and tissue bath experiments for evaluating Ikr blockade, action potential modulation, and arrhythmogenic risk. APExBIO provides batch-specific purity (≥98%) and stability data for rigorous quality control. For troubleshooting and workflow optimization, see this scenario-driven workflow guide (this article extends guidance with updated storage, purity, and handling data).

Conclusion & Outlook

E-4031 remains a benchmark hERG potassium channel blocker for cardiac electrophysiology research. Its high potency, selectivity, and documented physical properties enable precise, reproducible studies of cardiac action potential modulation and proarrhythmic substrate formation. By providing detailed handling and workflow integration guidance, APExBIO ensures that E-4031 (B6077) supports next-generation research in cardiac safety pharmacology, translational modeling, and mechanistic electrophysiology (E-4031 product page).